Skip to search formSkip to main contentSkip to account menu

Reteplase 10 UNT Injection [Retavase]

Known as: RETEPLASE 1.81 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Retavase], Retavase 10 UNT Injection, Retavase KIT 
National Institutes of Health

Related topics

Related topics

10 relations
Dibasic potassium phosphateInjectionPhosphoric acidPolysorbate 80

Broader (1)

Reteplase 10 UNT Injection

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Spotlight on Reteplase in Thrombotic Occlusive Disorders
Reteplase (Retavase®) is a plasminogen activator, mimicking endogenous tissue plasminogen activator (t-PA), a serine protease… 
2002
2002
Neuroprotection by Retavase® and Integrilin® alone or in combination for the treatment of embolic middle cerebral artery occlusion
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)